Fig 1.
Proportions of T1D, T2D and insulin resistance in the cross-sectional analysis at baseline (n = 570).
Table 1.
Descriptive population data of the patients without diabetes (n = 505) at baseline.
Fig 2.
Proportions of T1D, T2D and insulin resistance in the prospectively followed cohort at follow up (n = 505).
Table 2.
HIV-parameters, treatment, metabolic and inflammatory factors at baseline in relation to T2D development during follow up (n = 505).
Uni and multivariate analysis at baseline. The multivariate analysis was controlled for age. All parameters with p<0.20 in the univariate analysis were entered in the multivariate equation. Odds Ratio (OR) and 95% confidence interval.
Table 3.
Uni and multivariate analysis regarding T2D in all patients including patients with diabetes (n = 570) at baseline.
The multivariate analysis was controlled for age. All parameters with p<0.20 in the univariate analysis were entered in the multivariate equation. OR and 95% confidence interval.